Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gilabert

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Thrombosis Research|June 1, 1992
Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic statesF España, J Gilabert, V Vicente, et al.
Revista Clinica Espanola|March 1, 1991
[Malignant Mediterranean boutonneuse fever. Septic shock of unknown origin?]X Castella, T Villar, J Badal, et al.
Thrombosis and Haemostasis|June 28, 1990
Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsiaJ Gilabert, A Estellés, J Aznar, et al.
Thrombosis Research|September 15, 1982
Evaluation of the soluble fibrin monomer complexes and other coagulation parameters in obstetric patientsJ Aznar, J Gilabert, A Estelles, et al.
Haemostasis|July 1, 1994
Alterations in fibrinolytic and protein C pathways in gynaecological surgery: low molecular weight heparin prophylaxisA Estellés, J Gilabert, F España, et al.
Anales Otorrinolaringologicos Ibero-Americanos|January 1, 1991
[The imaging diagnosis of carotid body tumors]F de Juan-Burgueño, C F Muñoz Núñez, C López Orellana, et al.
Thrombosis and Haemostasis|December 20, 1993
Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasmaF España, A Estellés, P J Fernández, et al.
Clinical Chemistry|April 1, 1996
Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulinF España, J Sánchez-Cuenca, A Estellés, et al.
American Journal of Obstetrics and Gynecology|December 1, 1995
The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal statusJ Gilabert, A Estellés, A Cano, et al.
Current Medicinal Chemistry|March 30, 2012
Role of microRNAs in gynecological pathologyJ Gilabert-Estelles, A Braza-Boils, L A Ramon, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Thrombosis Research|June 1, 1992
Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic statesF España, J Gilabert, V Vicente, et al.
Revista Clinica Espanola|March 1, 1991
[Malignant Mediterranean boutonneuse fever. Septic shock of unknown origin?]X Castella, T Villar, J Badal, et al.
Thrombosis and Haemostasis|June 28, 1990
Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsiaJ Gilabert, A Estellés, J Aznar, et al.
Thrombosis Research|September 15, 1982
Evaluation of the soluble fibrin monomer complexes and other coagulation parameters in obstetric patientsJ Aznar, J Gilabert, A Estelles, et al.
Haemostasis|July 1, 1994
Alterations in fibrinolytic and protein C pathways in gynaecological surgery: low molecular weight heparin prophylaxisA Estellés, J Gilabert, F España, et al.
Anales Otorrinolaringologicos Ibero-Americanos|January 1, 1991
[The imaging diagnosis of carotid body tumors]F de Juan-Burgueño, C F Muñoz Núñez, C López Orellana, et al.
Thrombosis and Haemostasis|December 20, 1993
Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasmaF España, A Estellés, P J Fernández, et al.
Clinical Chemistry|April 1, 1996
Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulinF España, J Sánchez-Cuenca, A Estellés, et al.
American Journal of Obstetrics and Gynecology|December 1, 1995
The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal statusJ Gilabert, A Estellés, A Cano, et al.
Current Medicinal Chemistry|March 30, 2012
Role of microRNAs in gynecological pathologyJ Gilabert-Estelles, A Braza-Boils, L A Ramon, et al.
Pageof 8